Earnings summaries and quarterly performance for Evercore.
Executive leadership at Evercore.
Board of directors at Evercore.
Research analysts who have asked questions during Evercore earnings calls.
Brendan O'Brien
Wolfe Research
4 questions for EVR
Also covers: CG, HLI, LAZ +4 more
Devin Ryan
Citizens JMP
4 questions for EVR
Also covers: AMTD, COIN, CRCL +19 more
James Yaro
Goldman Sachs
4 questions for EVR
Also covers: COIN, CRCL, ETOR +11 more
Ryan Kenny
Morgan Stanley
4 questions for EVR
Also covers: C, HLI, LAZ +2 more
MB
Michael Brown
Wells Fargo Securities
3 questions for EVR
Also covers: APO, ARES, BAM +18 more
AH
Aidan Hall
KBW
2 questions for EVR
Also covers: HLI, HLNE, LAZ +5 more
Brent Thielman
D.A. Davidson
2 questions for EVR
Also covers: AAON, ACA, APOG +27 more
AB
Alex Bond
Keefe, Bruyette & Woods (KBW)
1 question for EVR
Also covers: HLI, LAZ, MC +3 more
BR
Ben Rubin
UBS
1 question for EVR
Also covers: BAM, CNS, HLI +5 more
BH
Brennan Hawken
UBS Group AG
1 question for EVR
Also covers: AMP, AMTD, APO +26 more
BB
Brian Brophy
Stifel Financial Corp
1 question for EVR
Also covers: CTOS, ECG, EME +10 more
CE
Christopher Ellinghaus
Siebert Williams Shank & Co., LLC
1 question for EVR
Also covers: BKH, CPK, CTRI +12 more
CS
Christopher Senyek
Wolfe Research
1 question for EVR
Also covers: BE, ECG, NATL +2 more
IZ
Ian Zaffino
Oppenheimer & Co. Inc.
1 question for EVR
Also covers: ACA, ALSN, ARMK +18 more
JM
James Mitchell
Seaport Global Holdings LLC
1 question for EVR
Also covers: BAC, BK, C +9 more
JM
Jim Mitchell
Seaport Global
1 question for EVR
Also covers: BAC, C, JPM +2 more
Michael Dudas
Vertical Research Partners
1 question for EVR
Also covers: AA, ACM, ARCH +15 more
Recent press releases and 8-K filings for EVR.
Mission Produce to Acquire Calavo Growers
EVR
M&A
New Projects/Investments
- Mission Produce will acquire Calavo Growers in a cash-and-stock transaction valued at approximately $430 million, representing a 26% premium to Calavo's 30-trading day volume weighted average price of $21.41.
- The acquisition is expected to generate $25 million of annualized cost synergies within 18 months post-close.
- The transaction is anticipated to close by the end of August 2026, subject to regulatory and shareholder approvals.
- This deal aims to bolster Mission's North American avocado business, diversify its produce portfolio with items like tomatoes and papayas, and expand into the high-growth prepared food segment, including guacamole.
5 days ago
First Brands Group Launches Sale Process to Emerge from Chapter 11
EVR
M&A
Legal Proceedings
New Projects/Investments
- First Brands Group has initiated a sale process for its business, either as a whole or in parts, to maximize stakeholder value and facilitate its emergence from Chapter 11 cases.
- The company is in discussions with an Ad Hoc Group of lenders to provide additional debtor-in-possession (DIP) financing and serve as a stalking horse bidder for certain business segments.
- The sale process is anticipated to conclude in the first quarter 2026, subject to court approval.
- Evercore is acting as the investment banker for the Ad Hoc Group of lenders.
Jan 7, 2026, 10:00 PM
Antin to Acquire NorthC Datacenters
EVR
M&A
New Projects/Investments
- Antin Infrastructure Partners has agreed to acquire NorthC Datacenters, a leading European enterprise colocation data centre platform, from DWS and other minority shareholders.
- The acquisition is being carried out through Antin’s Flagship Fund V and is expected to close in H1 2026, subject to regulatory approvals.
- NorthC operates 25 colocation data centres across the Netherlands, Germany, and Switzerland, serving over 1,600 blue-chip customers.
Dec 11, 2025, 6:00 AM
Evercore Discusses Growth, Strategic Expansion, and Market Outlook
EVR
M&A
Hiring
Share Buyback
- Evercore has significantly expanded its client footprint and market position, achieving number three globally in total advisory revenues.
- The company completed a strategic acquisition of Robey Warshaw to strengthen its European presence and has recruited 18 new Senior Managing Directors (SMDs) this year, with a focus on A-plus talent.
- Management believes the M&A cycle is in its early stages, with record backlogs and a strong pickup in sponsor activity, while the secondaries business is experiencing record growth.
- Evercore maintains a philosophy of returning capital to shareholders through continued share repurchases, having already repurchased stock related to the Robey Warshaw acquisition.
Dec 9, 2025, 2:20 PM
Evercore Chairman and CEO Discusses Growth, Market Outlook, and Capital Strategy
EVR
M&A
Hiring
Share Buyback
- Evercore has achieved significant growth, expanding its client footprint and market position to become the number three firm globally in total advisory revenues.
- The company made a strategic acquisition of Robey Warshaw to strengthen its European presence and large-cap relationships, alongside recruiting 18 Senior Managing Directors this year.
- Management believes the M&A and Equity Capital Markets (ECM) cycles are in their early stages and anticipate continued strength, with record backlogs and robust sponsor activity.
- Evercore's secondaries business is experiencing record growth, with the first three quarters of 2025 exceeding the entirety of 2024, and no expected slowdown.
- The firm is focused on improving its compensation ratio and continues its philosophy of repurchasing shares to return capital to shareholders.
Dec 9, 2025, 2:20 PM
Evercore Discusses Growth, Strategic Expansion, and Positive Market Outlook
EVR
M&A
Hiring
Share Buyback
- Evercore has achieved significant growth, expanding its client footprint and market share to become the third-largest firm globally in total advisory revenues.
- The firm strategically acquired Robey Warshaw to enhance its European and large-cap client reach and has recruited 18 Senior Managing Directors (SMDs) in 2025, with a strong talent pipeline.
- Evercore's secondaries business is on a record pace in 2025, surpassing all of 2024's performance in the first three quarters, and the company reports record backlogs with the fourth quarter of 2025 tracking well.
- Management views the M&A cycle as being in its early stages with continued strength expected, while the Equity Capital Markets (ECM) and restructuring businesses are also strengthening.
- The company maintains its commitment to repurchasing shares to return capital to shareholders, having already repurchased stock related to the Robey Warshaw acquisition.
Dec 9, 2025, 2:20 PM
Evercore Opens Riyadh Office and Receives License
EVR
Hiring
New Projects/Investments
- Evercore has received an Arranging License from the Capital Markets Authority in the Kingdom of Saudi Arabia and is opening an office in Riyadh to provide independent advisory services.
- The new Riyadh office will be led by Mohammed Aldekmary, who joined the firm in May 2025 and brings over two decades of experience in investment banking and financial services.
- This expansion reinforces Evercore's presence in the Middle East, which is a priority growth area for the firm, building on its existing Dubai office opened in 2017.
Dec 9, 2025, 10:00 AM
Evercore Opens Riyadh Office
EVR
New Projects/Investments
Hiring
- Evercore Inc. has established a new office in Riyadh, Saudi Arabia, after securing an arranging license from the Saudi Capital Markets Authority.
- This strategic expansion, led by Mohammed Aldekmary who joined in May 2025, aims to provide independent advisory services within Saudi Arabia and bolster Evercore's presence in the Middle East, identified as a priority growth area.
- Financially, Evercore reported a net margin of 14.92% and earnings per share of $12.55 with 60% earnings growth over the past year, despite a 3-year revenue growth decline of 2%.
Dec 9, 2025, 2:42 AM
Atea Pharmaceuticals Reports Q3 2025 Financial Results and Provides Business Update
EVR
Earnings
Share Buyback
New Projects/Investments
- Atea Pharmaceuticals reported cash, cash equivalents and marketable securities of $329.3 million as of September 30, 2025, compared to $454.7 million at December 31, 2024. For the three months ended September 30, 2025, the company recorded a net loss of $42.049 million and a net loss per share of $0.53.
- The global Phase 3 program for the bemnifosbuvir/ruzasvir regimen for Hepatitis C Virus (HCV) is progressing, with topline results for the C-BEYOND trial in North America expected in mid-2026 and for the C-FORWARD trial (outside North America) around the end of 2026.
- The company expanded its antiviral pipeline with a new Hepatitis E Virus (HEV) development program, anticipating Phase 1 studies for its lead candidates, AT-587 and AT-2490, to begin in mid-2026.
- Atea completed its share repurchase program, buying back 7,673,793 shares at an average price of $3.26 per share, resulting in 78,126,796 shares outstanding.
Nov 12, 2025, 9:05 PM
Precision Concepts International Acquires Comar
EVR
M&A
New Projects/Investments
- Precision Concepts International (PCI), a portfolio company of The Sterling Group, has acquired Comar.
- This acquisition establishes a scaled rigid packaging platform serving diverse consumer and healthcare customers across North America.
- The combination is expected to enhance PCI's capabilities, broaden its product and service offerings, and provide enhanced geographic, customer, and end market diversification.
- Evercore acted as the financial advisor to PCI for this transaction.
Nov 4, 2025, 2:00 PM
Quarterly earnings call transcripts for Evercore.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more